Tamar F. Barlam
-
- Antibiotic Use and Resistance 19
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 9
- Clostridium difficile and Clostridium perfringens research 4
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 12
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 7
- Pneumocystis jirovecii pneumonia detection and treatment 4
- Microscopic Colitis 3
- Molecular Medicine top 5%
-
- Patient Satisfaction in Healthcare 8
- Co-authors
- Grace Y. MinamotoKeith A. ReimannElizabeth RaceNicholas VanderGila KriegelNorman L. LetvinAnthony J. JapourHarold C. Neu
- Journals
- The Lancet (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Tamar F. Barlam
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 94
- Applied Microbiology and Biotechnology 351
- Infectious Diseases 578
- Clinical Biochemistry 200
- Epidemiology 695
- Molecular Medicine 99
Countries citing papers authored by Tamar F. Barlam
This map shows the geographic impact of Tamar F. Barlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar F. Barlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar F. Barlam more than expected).
Fields of papers citing papers by Tamar F. Barlam
This network shows the impact of papers produced by Tamar F. Barlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar F. Barlam. The network helps show where Tamar F. Barlam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tamar F. Barlam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 2 | |
| 3 | 2022 | 16 | |
| 4 | 2021 | 28 | |
| 5 | 2021 | 7 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 6 | |
| 8 | 2020 | 52 | |
| 9 | 2018 | 5 | |
| 10 | 2018 | 5 | |
| 11 | Patient-Provider Race and Sex Concordance: New Insights into Antibiotic Prescribing for Acute Bronchitis | 2017 | 2 |
| 12 | 2017 | 15 | |
| 13 | 2015 | 5 | |
| 14 | An Update on the Infectious Diseases Society of America & Society for Healthcare Epidemiology of America Antimicrobial Stewardship Implementation Guidelines | 2014 | 2 |
| 15 | 2006 | 22 | |
| 16 | 2000 | 18 | |
| 17 | 1998 | 113 | |
| 18 | 1998 | 42 | |
| 19 | 1996 | 20 | |
| 20 | 1992 | 115 |
About Tamar F. Barlam
Tamar F. Barlam is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Infectious Diseases, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (19 papers), Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Patient Satisfaction in Healthcare (8 papers), Pneumonia and Respiratory Infections (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Microscopic Colitis (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (351 citations), Infectious Diseases (578 citations) and Clinical Biochemistry (200 citations). Tamar F. Barlam has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Grace Y. Minamoto, Keith A. Reimann, Elizabeth Race, Nicholas Vander, Gila Kriegel, Norman L. Letvin, Anthony J. Japour, Harold C. Neu, Timothy Flanigan and Josiah D. Rich. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.